Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celestica (CLS) Research & Development (2016 - 2026)

Celestica has reported Research & Development over the past 16 years, most recently at $41.2 million for Q1 2026.

  • Quarterly Research & Development rose 134.09% to $41.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $141.8 million through Mar 2026, up 79.27% year-over-year, with the annual reading at $118.2 million for FY2025, 51.54% up from the prior year.
  • Research & Development was $41.2 million for Q1 2026 at Celestica, up from $30.2 million in the prior quarter.
  • Over five years, Research & Development peaked at $41.2 million in Q1 2026 and troughed at $8.8 million in Q2 2022.
  • The 5-year median for Research & Development is $17.6 million (2023), against an average of $20.3 million.
  • Year-over-year, Research & Development decreased 2.22% in 2022 and then surged 134.09% in 2026.
  • A 5-year view of Research & Development shows it stood at $14.5 million in 2022, then rose by 21.38% to $17.6 million in 2023, then skyrocketed by 32.95% to $23.4 million in 2024, then grew by 29.06% to $30.2 million in 2025, then surged by 36.42% to $41.2 million in 2026.
  • Per Business Quant, the three most recent readings for CLS's Research & Development are $41.2 million (Q1 2026), $30.2 million (Q4 2025), and $36.4 million (Q3 2025).